Medical device company Biovo Technologies Ltd revealed on Thursday that it has commissioned its Cuffix devices in the largest newly established COVID-19 ward in one of Israel's leading hospitals, with a capacity of 170 ventilated patients.
The company added that Cuffix is the first and only economical, self-contained, disposable cuff pressure regulator and monitor in the market.
As ICUs are full and medical personnel is stretched to the limit, the single use products including Cuffix can assist with treating COVID-19 patients and reduce nurse work load. This has dramatically increased worldwide interest in Biovo's products.
Under the company's plan to increase sales and production volumes, it has signed distribution agreements in Australia and Brazil and following the recent 510K FDA clearance, the next commercialization step is in the USA and discussions are already underway.
Airiver Medical's Airiver Pulmonary DCB receives US FDA Breakthrough Device Designation
BD receives FDA clearance for Surgiphor 1000mL irrigation system
Galderma secures EU, US and Canada approval for new Restylane syringe
Philips launches InkSpace Imaging Snuggle coil for 3.0T MRI systems
Realheart secures European patent for artificial heart technology
Median Technologies secures FDA clearance for AI lung cancer screening software
Eli Lilly to invest over USD3.5bn in new Pennsylvania plant
Spine Innovation's LOGIC Titanium Implant System receives US FDA 510(k) market approval
Apiject to open new generic injectable drug manufacturing facility in Apex, NC
Zylox-Tonbridge agrees staged acquisition of Germany's Optimed
Kestra partners with Biobeat to add cuffless blood pressure monitoring to wearable defibrillator
Boston Scientific to acquire Valencia Technologies to expand overactive bladder portfolio
EQT Life Sciences exits Vivasure Medical in EUR185m sale to Haemonetics